Company Search:
Advanced Search
Sponsored Links
Genocea Biosciences Inc Company Snapshot
Genocea Biosciences Inc operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Genocea Biosciences Inc with three other companies in this sector in the United States: Karyopharm Therapeutics Inc (2016 sales of $154,000.00 ), Syros Pharmaceuticals Inc ($317,000.00 of which 100% was Pharmaceutical), and Scynexis Inc ($257,000.00 ).

Sales Analysis. During the year ended December of 2016, sales at Genocea Biosciences Inc were $235,000.00 . This is a sharp decrease of 64.9% versus 2015, when the company's sales were $670,000.00 .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Genocea Biosciences Inc
  Stock Performance Chart for Genocea Biosciences Inc
  Stock Data: Recent Stock Performance:
  Current Price (1/12/2018): 1.13
(Figures in U.S. Dollars)
1 Week 0.4%   13 Weeks 5.1%  
4 Weeks -30.1%   52 Weeks -74.4%  
Genocea Biosciences Inc Key Data:
  Ticker: GNCA Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 235,000
(Year Ending Jan 2017).
Employees: 98
  Currency: U.S. Dollars Market Cap: 32,292,185
  Fiscal Yr Ends: December Shares Outstanding: 28,704,164
  Share Type: Ordinary Closely Held Shares: 2,281,228
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.